Optiver Holding
AGIO icon

Optiver Holding’s Agios Pharmaceuticals AGIO Stock Holding History

Optiver Holding’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-108
Closed -$3.65K – 2757
2026
Q1 		$3.65K Buy
+108
New +$3.06K ﹤0.01% 1565
2025
Q4 		– Sell
-310
Closed -$12.4K – 2455
2025
Q3 		$12.4K Buy
310
+5
+2% +$188 ﹤0.01% 1165
2025
Q2 		$10.1K Buy
305
+90
+42% +$2.73K ﹤0.01% 1004
2025
Q1 		$6.3K Buy
+215
New +$7.13K ﹤0.01% 1031

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Optiver Holding's AGIO Position: Q2 2026 in Review

Optiver Holding sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 108 shares — an estimated $3.65K sold.

Optiver Holding first reported a position in AGIO in Q1 2025 and held it in 4 quarters. The position peaked at $12.4K in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Optiver Holding reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 108 Agios Pharmaceuticals shares in Q2 2026, an estimated $3.65K.
  • Optiver Holding first reported a position in Agios Pharmaceuticals in Q1 2025 and held it in 4 quarters.
  • Optiver Holding's Agios Pharmaceuticals position peaked at $12.4K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.